Primary |
Product Used For Unknown Indication |
24.8% |
Cellulitis |
11.6% |
Tooth Infection |
8.2% |
Infection |
6.9% |
Prophylaxis |
4.7% |
Tooth Abscess |
4.5% |
Staphylococcal Infection |
4.4% |
Hypertension |
4.2% |
Pain |
3.5% |
Mastitis |
3.4% |
Antibiotic Prophylaxis |
2.9% |
Localised Infection |
2.7% |
Muscular Weakness |
2.5% |
Sinusitis |
2.5% |
Tooth Extraction |
2.5% |
Endodontic Procedure |
2.3% |
Gouty Arthritis |
2.3% |
Infection Prophylaxis |
2.2% |
Vitamin Supplementation |
2.0% |
Acne |
1.8% |
|
Rash |
12.4% |
Diarrhoea |
10.0% |
Vomiting |
8.6% |
Acute Generalised Exanthematous Pustulosis |
6.6% |
Clostridium Difficile Colitis |
6.6% |
Weight Decreased |
6.6% |
Renal Failure Acute |
5.2% |
Drug Interaction |
4.8% |
Urticaria |
4.8% |
Nausea |
4.1% |
Malaise |
3.4% |
Rash Generalised |
3.4% |
Swelling Face |
3.4% |
Pruritus |
3.1% |
Stevens-johnson Syndrome |
3.1% |
Tubulointerstitial Nephritis |
3.1% |
Vasculitis Necrotising |
3.1% |
Pyrexia |
2.8% |
Clostridial Infection |
2.4% |
Liver Injury |
2.4% |
|
Secondary |
Product Used For Unknown Indication |
35.5% |
Drug Abuse |
9.5% |
Drug Use For Unknown Indication |
6.5% |
Pyrexia |
6.1% |
Sinusitis |
4.6% |
Pharyngitis |
4.0% |
Cellulitis |
3.8% |
Headache |
3.6% |
Ill-defined Disorder |
3.3% |
Hypertension |
3.1% |
Foetal Exposure During Pregnancy |
3.0% |
Pain |
2.5% |
Prophylaxis |
2.4% |
Hiv Infection |
2.1% |
Tooth Infection |
2.1% |
Infection |
1.8% |
Acne |
1.6% |
Pneumonia |
1.5% |
Neutropenic Sepsis |
1.5% |
Agitation |
1.4% |
|
Rash |
8.1% |
Vomiting |
8.1% |
Weight Decreased |
7.1% |
Completed Suicide |
6.6% |
Renal Failure Acute |
6.1% |
Toxic Epidermal Necrolysis |
6.1% |
Pyrexia |
5.6% |
Urticaria |
5.6% |
Ventricular Extrasystoles |
5.6% |
Wheezing |
5.1% |
Pseudomembranous Colitis |
4.0% |
White Blood Cell Count Decreased |
4.0% |
Acute Generalised Exanthematous Pustulosis |
3.5% |
Death |
3.5% |
Drug Hypersensitivity |
3.5% |
Drug Ineffective |
3.5% |
Drug Interaction |
3.5% |
International Normalised Ratio Increased |
3.5% |
Liver Injury |
3.5% |
Stevens-johnson Syndrome |
3.5% |
|
Concomitant |
Product Used For Unknown Indication |
36.3% |
Drug Use For Unknown Indication |
10.8% |
Pain |
7.7% |
Hypertension |
5.3% |
Multiple Myeloma |
4.9% |
Prophylaxis |
4.3% |
Acne |
3.5% |
Rheumatoid Arthritis |
2.8% |
Hiv Infection |
2.6% |
Contraception |
2.6% |
Depression |
2.3% |
Nausea |
2.2% |
Osteoporosis |
2.2% |
Breast Cancer |
2.2% |
Infection |
2.0% |
Metastases To Bone |
2.0% |
Anxiety |
1.9% |
Pyrexia |
1.5% |
Diabetes Mellitus |
1.5% |
Rash |
1.5% |
|
Weight Decreased |
17.5% |
Vomiting |
13.0% |
Pulmonary Embolism |
7.2% |
Sepsis |
6.3% |
Pain |
5.2% |
Tooth Extraction |
4.5% |
Vision Blurred |
4.4% |
Wound Infection Staphylococcal |
4.4% |
Urinary Tract Infection |
4.2% |
Weight Increased |
3.8% |
Deep Vein Thrombosis |
3.4% |
Nausea |
3.2% |
Rash |
3.2% |
Thrombocytopenia |
3.2% |
Pneumonia |
3.1% |
White Blood Cell Count Decreased |
3.1% |
Renal Failure Acute |
2.9% |
Anxiety |
2.5% |
Death |
2.5% |
Pyrexia |
2.5% |
|
Interacting |
Pain |
10.4% |
Depression |
9.0% |
Hypertension |
9.0% |
Subcutaneous Abscess |
9.0% |
Antibiotic Prophylaxis |
6.0% |
Drug Use For Unknown Indication |
6.0% |
Gouty Arthritis |
6.0% |
Nosocomial Infection |
6.0% |
Staphylococcal Infection |
6.0% |
Abdominal Pain |
3.0% |
Anaemia |
3.0% |
Ankylosing Spondylitis |
3.0% |
Asthma |
3.0% |
Atrial Fibrillation |
3.0% |
Cellulitis |
3.0% |
Coronary Artery Disease |
3.0% |
Dyspepsia |
3.0% |
Extrapyramidal Disorder |
3.0% |
Gastrooesophageal Reflux Disease |
3.0% |
Helicobacter Gastritis |
3.0% |
|
Drug Interaction |
29.4% |
Retroperitoneal Haemorrhage |
11.8% |
Stevens-johnson Syndrome |
11.8% |
Tremor |
11.8% |
White Blood Cell Count Decreased |
11.8% |
Clostridium Difficile Colitis |
5.9% |
Pneumonia Aspiration |
5.9% |
Urinary Tract Infection Bacterial |
5.9% |
Withdrawal Syndrome |
5.9% |
|